The Voice of Rheumatology (VOR) Coalition convened last month at ACR Convergence 2024 in Washington, D.C., to discuss the pressing federal and state legislative priorities that will affect both the practice of rheumatology and patient care in the year ahead. The Coalition, composed of leading rheumatology professional societies and patient advocacy groups, gathered to examine…
Billing and Coding Updates for G2211 in 2025
On Nov. 1, the Centers for Medicare & Medicaid Services finalized its proposal for an incremental expansion of the G2211 add-on code for complexity.
What Providers & Patients Should Know About Medicare Benefit Changes in 2025
Changes to Medicare benefits in 2025 include an annual $2,000 cap on out-of-pocket costs for covered Part D drugs and a new, voluntary Medicare Prescription Payment Plan intended to help beneficiaries manage drug costs.
Telemedicine Flexibilities for Controlled Substance Prescriptions Extended Through 2025
A third extension of telemedicine flexibilities will continue to allow prescription of controlled substances via telemedicine without an in-person visit through the end of 2025.
2024 Rheumatology Fellowship Match Day Results
Match Day Results Highlight Continued Interest in Adult Rheumatology & Sharp Declines in Pediatric Rheumatology The ACR applauds another successful recruitment season for rheumatology and welcomes an impressive pool of applicants to the specialty. Ninety-nine percent of adult rheumatology positions were filled for the 2024 appointment year as part of the National Resident Matching Program…
Prevalence of Fibromyalgia & Widespread Pain in Psoriatic Arthritis: Association with Disease Severity Assessment in a Large U.S. Registry
According to a new study, fibromyalgia prevalence is elevated in PsA and is associated with elevated disease measures, confounding reliable disease assessment for treat-to-target goals.
What Clinical Factors Affect Length of Transition to Psoriatic Arthritis in Patients with Psoriasis?
Objective We aimed to identify clinical and demographic features associated with the interval between the appearance of psoriasis and the onset of psoriatic arthritis (PsA). Methods We identified patients with psoriasis and PsA diagnoses from our tertiary care psoriatic disease biorepository: a longitudinal, real-world database including clinical information and patient-reported outcomes. We used a multivariable,…
RheumPAC Helps ACR ‘Stand Up for What’s Important’
Kaitlyn Brittan, MD, the newest chair of the ACR’s RheumPAC Committee, views advocacy as a core principle of caring for patients, with meaningful, real-world impact.
The 5 Ms: A Simple Framework to Care for Older Patients
WASHINGTON, D.C.—For the first time in U.S. history, older adults are projected to outnumber children by 2034, and their care poses unique challenges to the rheumatologist.1 Normal physiologic changes of aging include but aren’t limited to falling renal function, changes in pharmacokinetics and bone density loss. At the ACR Convergence 2024 Review Course, Namrata Singh,…
FDA Officials Discuss Extrapolation & Confusion Around Pediatric Therapies
A session at ACR Convergence 2024 addressed several recent drug approvals in pediatric rheumatology and a safety update for IL-1/IL-6 inhibitors.
- « Previous Page
- 1
- …
- 6
- 7
- 8
- 9
- 10
- …
- 317
- Next Page »